About Behold.ai
Behold.ai is a medical imaging AI company that develops advanced artificial intelligence solutions to assist radiologists and healthcare providers in analyzing medical images. The company specializes in AI-powered analysis of chest X-rays and other radiological imaging, helping to detect abnormalities, prioritize urgent cases, and accelerate diagnostic workflows. Behold.ai's flagship products have received regulatory clearances including FDA approval and CE marking, demonstrating clinical validation and safety for use in healthcare settings. The company's technology is designed to integrate seamlessly into existing radiology workflows, working alongside radiologists to enhance diagnostic accuracy while reducing reporting times. By leveraging deep learning and computer vision techniques, Behold.ai's solutions can identify potential pathologies and flag critical findings for immediate attention. The company serves hospitals, imaging centers, and healthcare systems globally, with a focus on improving patient outcomes through faster, more accurate diagnoses. Behold.ai's mission centers on democratizing access to high-quality diagnostic imaging interpretation, particularly in settings where radiologist shortages or high workloads may impact care delivery. The company continues to expand its product portfolio and geographic reach, working with healthcare partners to validate clinical outcomes and refine its AI models based on real-world performance data.
Clinical Focus
Medical conditions and clinical areas addressed by Behold.ai.
Who It Serves
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.